Centro de Recursos

Esta sección contiene investigaciones internacionales y puede hacer referencia a indicaciones que no están aprobadas en todas las regiones. Consulte las indicaciones aprobadas localmente antes de su uso.

Filtrado por:

Buscar

Click On The Read More Below To Request The Document

Click On The Read More Below To Request The Document

Click on the read more below to request the document

OMER, Israel, Feb 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month

We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo

The News Pulse

Le invitamos a mantenerse al día con las más recientes actualizaciones registrándose a nuestro boletín trimestral

Preguntas frecuentes

Preguntas frecuentes